• A Lesion Surrounded by the Rainbow: Merkel Cell Carcinoma
• A Novel Artificial Intelligence-based Parameterization Approach of the Stromal Landscape in Merkel Cell Carcinoma: a Multi-Institutional Study
• A rapidly growing ulcer: an atypical presentation of Merkel cell carcinoma
• A retrospective case-control analysis of various comorbidities associated with Merkel Cell Carcinoma
• Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
• Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation
• Applications of cell therapy in the treatment of virus-associated cancers
• ASO Author Reflections: Neoadjuvant Immunotherapy for Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis?
• ASO Visual Abstract: The Role of Neoadjuvant Immunotherapy in the Management of Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis
• Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database
• Basal cell carcinoma in situ of the skin revisited: case reports of the superficial type and fibroepithelioma type of this in situ cutaneous neoplasm
• Biomarker analyses investigating disease biology and associations with outcomes in the JAVELIN Merkel 200 trial of avelumab in metastatic Merkel cell carcinoma
• Brazilian Society of Surgical Oncology recommendations on Merkel cell carcinoma surgical treatment
• Casein kinase 1alpha mediates phosphorylation of the Merkel cell polyomavirus large T antigen for beta-TrCP destruction complex interaction and subsequent degradation
• Cellular Transformation by Human Cytomegalovirus
• Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence
• Chemoreactive 2,5-Diketopiperazines from a <em>Penicillium</em> sp., Structure Revision of Reported Analogues and Proposed Facile Transformation Pathways
• Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications
• Correction: Addressing disparities: a cross-sectional analysis of diversity in Merkel cell carcinoma clinical trials
• Corrigendum to "Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma" [Neoplasia, Volume 21, Issue 3 (2019) 322-330]
• Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update
• Current status of Merkel cell carcinoma: Epidemiology, pathogenesis and prognostic factors
• Cutaneotropic Polyomavirus Abundance in the Non-lesional Skin of Keratinocyte Carcinoma Patients: A Cross-sectional Study
• Cutaneotropic polyomavirus abundance in the nonlesional skin of keratinocyte carcinoma patients: A cross-sectional study
• Dermoscopic characteristics of Merkel cell carcinoma
• Different prognosis in cutaneous early-onset and late-onset Merkel cell carcinoma: a population-based retrospective study
• DNA damage stress control is a tLT- and EHMT2-dependent central feature of Merkel Cell Carcinoma
• DNA Damage Stress Control Is a Truncated Large T Antigen and Euchromatic Histone Lysine Methyltransferase 2-Dependent Central Feature of Merkel Cell Carcinoma
• Early postoperative infection in patient with IgM deficiency
• Epidemiology and primary site of Merkel cell carcinoma among black patients: results from a national cancer registry
• Exploring the therapeutic modalities of targeted treatment approach for skin carcinoma: cutting-edge strategies and key insights
• Fluorodeoxyglucose-avid cosmetic poly-L-lactic acid filler on surveillance imaging for Merkel cell carcinoma
• Genomic profiles of Merkel cell carcinoma in Japan
• High cardiovascular mortality risk among older merkel cell carcinoma patients
• High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
• Hispanic patients with Merkel cell carcinoma have lower mortality compared to non-Hispanic patients in the National Cancer Database
• Immune Checkpoint Inhibitor Therapy for Periocular Merkel Cell Carcinoma
• Impact of the adjunction of a short video to an original article for the recognition of newly described tumor entities in pathology: An interventional prospective study
• Incidence and Relative Survival of Patients with Merkel Cell Carcinoma in North Rhine-Westphalia, Germany, 2008-2021
• Incidence of Suicide Among Melanoma and Non-Keratinocyte Skin Cancer Patients in the US, 2000-2020
• Incidence of suicide among melanoma and nonkeratinocyte skin cancer patients in the United States, 2000-2020
• Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review
• Increased Risk of Keratinocyte Carcinomas, Merkel Cell Carcinoma, and Other Skin Cancers in Patients Treated With Janus Kinase 1 and 2 Inhibitor, Ruxolitinib
• Inpatient prevalence and factors associated with Merkel Cell Carcinoma inpatient hospitalization in the United States
• Introducing MCC-PS: a novel prognostic score for Merkel cell carcinoma
• ISLET-1 expression in soft tissue neoplasms reveals high sensitivity but moderate specificity for desmoplastic small round cell tumors and potential utility as a diagnostic biomarker
• JAAD Game Changers: "Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC)"
• JAAD Game Changers: Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC)
• Jimmy Buffett's death from Merkel cell carcinoma was associated with an increase in online search activity related to skin cancer
• JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression
• Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes
• Late subsequent Merkel cell carcinoma after 21 years of the first primary diagnosis: When to de-escalate surveillance?
• Localized Merkel cell carcinoma treatment considerations: a response to the forty-year experience at the Peter MacCallum cancer centre
• Lower Eyelid Merkel Cell Carcinoma in a Non-Immunocompromised Young Female: A Case Report
• Magnetic seed localization is feasible for non-palpable melanoma, Merkel cell carcinoma, and soft tissue sarcoma lesions
• Mapping of Human Polyomavirus in Renal Cell Carcinoma Tissues
• Mast cell density in Merkel cell carcinoma and its correlation with prognostic features and MCPyV status: a pilot study
• Merkel Cell Carcinoma
• Merkel cell carcinoma associated with TNF inhibitor therapy: a systematic review of case reports
• Merkel cell carcinoma in non-White Hispanic patients: Demographics and primary site
• Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy
• Merkel Cell Carcinoma With Extensive Bone Marrow Metastasis and Peripheral Blood Involvement: A Case Report With Immunohistochemical and Mutational Studies
• Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
• Merkel Cell Polyomavirus and their Association with the Pathogenesis of Cervical Squamous Cell Carcinomas and Adenocarcinomas: A Review Article
• Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1
• Merkel cell polyomavirus protein ALTO modulates TBK1 activity to support persistent infection
• Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling
• Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration
• Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
• No difference in overall survival for primary cutaneous Merkel cell carcinoma after Mohs micrographic surgery and wide local excision: A multicenter cohort analysis
• Outcomes of Merkel Cell Carcinoma in the Era of Immune Checkpoint Blockade
• Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway
• Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway
• Possible association between polyomaviruses and gastrointestinal complications: a narrative review
• PRAME Expression in Merkel Cell Carcinoma
• Pre-existing skin-resident CD8 and gd T cell circuits mediate immune response in Merkel cell carcinoma and predict immunotherapy efficacy
• Profound ctDNA and radiological responses after 2 cycles of avelumab in a metastatic Merkel cell carcinoma of the head and neck
• Quality of life and patient-reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy
• Recurrent Merkel Cell Carcinoma Following COVID-19 Treatment
• Retrospective Single-Center Case Study of Clinical Variables and the Degree of Actinic Elastosis Associated with Rare Skin Cancers
• Searching for biomarkers to help distinguish Merkel cell carcinoma from cutaneous small cell lung cancer with gene expression analysis
• Simultaneous merkel cell carcinoma and acute myeloid leukaemia: A diagnostic challenge
• spatialGE: A user-friendly web application to democratize spatial transcriptomics analysis
• Steeper incidence rate and advanced staging of Merkel cell carcinoma in black patients
• Subsequent primary malignancies following first diagnosis of Merkel cell carcinoma in black patients
• Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
• The association between infectious agents and breast cancer: a review of the epidemiologic evidence
• The Clinical Utility of Teledermatology in Triaging and Diagnosing Skin Malignancies: Case Series
• The effect of selinexor on prostaglandin synthesis in virus-positive Merkel cell carcinoma cell lines
• The impact of DNA tumor viruses in low-to-middle income countries (LMICS): A literature review
• The Role of Neoadjuvant Immunotherapy in the Management of Merkel Cell Carcinoma with Clinically Detected Regional Lymph Node Metastasis
• The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods
• The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature
• The small tumor antigen of Merkel cell polyomavirus accomplishes cellular transformation by uniquely localizing to the nucleus despite the absence of a known nuclear localization signal
• Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities
• Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma
• Upper and Lower Eyelid Malignancies: Differences in Clinical Presentation, Metastasis, and Treatment
• Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
• Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies?
• Wnt/beta-catenin activated non pilomatrical carcinoma of the skin: a case series